Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
PsyPost on MSN11d
Experiences of awe may drive ketamine’s antidepressant benefitsA recent study examining the effects of ketamine infusion on depression found that the infusion induces psychological ...
Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours remission, and ketamine is also being marketed for post-traumatic stress ...
Elon Musk said in a March 2024 interview that he takes ketamine to treat depression. He claimed to have a doctor's prescription for the drug. How often, or under what circumstances, he uses ...
US Weekly on MSN6d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
New research involving ketamine continues show that having a mystical experience is key to the effectiveness of psychedelic ...
While ketamine is celebrated as a breakthrough depression treatment, new research highlights a significant rise in its ...
This can then be followed by a dexmedetomidine infusion (1–2 μg/kg/hr) with supplemental bolus doses of ketamine (0.5–1 mg/kg) as needed. Conclusions: The available literature except for one ...
Dr. David Mahjoubi, a highly respected board-certified anesthesiologist and the founder of Ketamine Healing Clinic of Los Angeles and OC, has been recognized as a 2025 Top Patient Rated Doctor by Find ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback